ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Varmus Confirmation On Fast Track, Nominee Outlines Goals For Next Year

November 12, 1993

Two NCI Officials Leave for Industry, Academia: Carl Barrett Goes to Novartis, Karen Antman Named Provost and Dean at Boston University.

February 18, 2005

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

May 25, 2012

Spending Measures Include Provisions On Ethics For NIH Extramural Scientists.

July 11, 2008

Neural Stem Cells Track, Treat, Brain Tumors In Mice

November 29, 2002

Four Detroit Institutions Merge Cancer Clinical, Research Programs

July 15, 1994